CRNX — Crinetics Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $9.00bn
- $7.80bn
- $7.70m
Brief: Crinetics Pharmaceuticals Announces Pricing Of 10 Mln Shares At $50 Each
Brief: Crinetics Pharmaceuticals Announces Proposed Public Offering Of Common Stock
Crinetics Pharma falls on planned $400 mln stock offering
Brief: Crinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly
Crinetics Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Crinetics Pharmaceuticals Inc expected to post a loss of 86 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Alphabet, Domino's Pizza, McKesson
Brief: Crinetics Pharmaceuticals Inc - Offer And Sale Of Up To $350.0 Million Of Shares
Brief: Crinetics Pharmaceuticals Inc Files For Mixed Shelf Size Not Disclosed - SEC Filing
U.S. RESEARCH ROUNDUP-Honeywell International, Stericycle, Target Corp
Brief: Crinetics Says TouCAHn Study Is Ongoing, With Topline Results From Complete Study Expected In H2 2024
Brief: Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., As Senior Vice President Of Medical Affairs
U.S. RESEARCH ROUNDUP-Analog Devices, NVIDIA, Snowflake
U.S. RESEARCH ROUNDUP- Corpay, Epam Systems, MKS Instruments
Crinetics Pharmaceuticals Inc reports results for the quarter ended in January - Earnings Summary
Brief: Crinetics Pharmaceuticals Q1 Net Income USD -66.93 Million
Crinetics Pharmaceuticals Inc expected to post a loss of 81 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- ServiceNow, Ulta Beauty, Vertex Pharmaceuticals
Crinetics Pharmaceuticals Inc expected to post a loss of 81 cents a share - Earnings Preview